Sbi Securities Co., Ltd. Neuro Sense Therapeutics Ltd. Transaction History
Sbi Securities Co., Ltd.
- $3 Trillion
- Q1 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 175 shares of NRSN stock, worth $266. This represents 0.0% of its overall portfolio holdings.
Number of Shares
175
Previous 175
-0.0%
Holding current value
$266
Previous $210,000
22.38%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NRSN
# of Institutions
12Shares Held
195KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY50.5KShares$76,7610.0% of portfolio
-
Meitav Dash Investments LTD40KShares$60,8000.0% of portfolio
-
Xtx Topco LTD London, X033.7KShares$51,2330.0% of portfolio
-
Commonwealth Equity Services, LLC17.3KShares$26,2200.0% of portfolio
-
Geode Capital Management, LLC Boston, MA15.9KShares$24,1220.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $17.7M